231 related articles for article (PubMed ID: 23403252)
41. Myogenesis in Wilms' tumors is associated with mutations of the WT1 gene and activation of Bcl-2 and the Wnt signaling pathway.
Fukuzawa R; Heathcott RW; Sano M; Morison IM; Yun K; Reeve AE
Pediatr Dev Pathol; 2004; 7(2):125-37. PubMed ID: 14994125
[TBL] [Abstract][Full Text] [Related]
42. Wilms' tumor protein Wt1 is an activator of the anti-Müllerian hormone receptor gene Amhr2.
Klattig J; Sierig R; Kruspe D; Besenbeck B; Englert C
Mol Cell Biol; 2007 Jun; 27(12):4355-64. PubMed ID: 17420277
[TBL] [Abstract][Full Text] [Related]
43. A review of the phenotypic variation due to the Denys-Drash syndrome-associated germline WT1 mutation R362X.
Heathcott RW; Morison IM; Gubler MC; Corbett R; Reeve AE
Hum Mutat; 2002 Apr; 19(4):462. PubMed ID: 11933209
[TBL] [Abstract][Full Text] [Related]
44. Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of a computerized mutation database.
Jeanpierre C; Denamur E; Henry I; Cabanis MO; Luce S; Cécille A; Elion J; Peuchmaur M; Loirat C; Niaudet P; Gubler MC; Junien C
Am J Hum Genet; 1998 Apr; 62(4):824-33. PubMed ID: 9529364
[TBL] [Abstract][Full Text] [Related]
45. WT1 mutations and polymorphisms in Southeast Asian acute myeloid leukemia.
Lauhakirti D; Sritana N; Boonthimat C; Promsuwicha O; Auewarakul CU
Exp Mol Pathol; 2011 Dec; 91(3):682-6. PubMed ID: 21798259
[TBL] [Abstract][Full Text] [Related]
46. Wilms tumor genetics: mutations in WT1, WTX, and CTNNB1 account for only about one-third of tumors.
Ruteshouser EC; Robinson SM; Huff V
Genes Chromosomes Cancer; 2008 Jun; 47(6):461-70. PubMed ID: 18311776
[TBL] [Abstract][Full Text] [Related]
47. A novel WT1 gene mutation in a newborn infant diagnosed with Denys-Drash syndrome.
Hakan N; Aydin M; Erdogan O; Cavusoglu YH; Aycan Z; Ozaltin F; Zenciroglu A; Apaydin S; Gunes R; Sahin G; Cinar G; Okumus N
Genet Couns; 2012; 23(2):255-61. PubMed ID: 22876585
[TBL] [Abstract][Full Text] [Related]
48. Transcriptional regulation by the Wilms' tumour suppressor protein WT1.
Wagner KJ; Roberts SG
Biochem Soc Trans; 2004 Dec; 32(Pt 6):932-5. PubMed ID: 15506928
[TBL] [Abstract][Full Text] [Related]
49. Role of the WT1 gene in Wilms' tumour.
Haber DA; Housman DE
Cancer Surv; 1992; 12():105-17. PubMed ID: 1322241
[TBL] [Abstract][Full Text] [Related]
50. Analysis of native WT1 protein from frozen human kidney and Wilms' tumors.
Iben S; Royer-Pokora B
Oncogene; 1999 Apr; 18(15):2533-6. PubMed ID: 10229205
[TBL] [Abstract][Full Text] [Related]
51. Altered trans-activational properties of a mutated WT1 gene product in a WAGR-associated Wilms' tumor.
Park S; Tomlinson G; Nisen P; Haber DA
Cancer Res; 1993 Oct; 53(20):4757-60. PubMed ID: 8402654
[TBL] [Abstract][Full Text] [Related]
52. Familial Wilms tumor.
Ruteshouser EC; Huff V
Am J Med Genet C Semin Med Genet; 2004 Aug; 129C(1):29-34. PubMed ID: 15264270
[TBL] [Abstract][Full Text] [Related]
53. Molecular evidence of the independent origin of multiple Wilms tumors in a case of WAGR syndrome.
Uccini S; Perotti D; Colarossi C; Stoppacciaro A; Sardella M; Mannarino O; Collini P; Casieri P; Cozzi D; Amoroso L; Spreafico F; Radice P; Dominici C
Pediatr Blood Cancer; 2008 Sep; 51(3):344-8. PubMed ID: 18293378
[TBL] [Abstract][Full Text] [Related]
54. A novel WT1 heterozygous nonsense mutation (p.K248X) causing a mild and slightly progressive nephropathy in a 46,XY patient with Denys-Drash syndrome.
da Silva TE; Nishi MY; Costa EM; Martin RM; Carvalho FM; Mendonca BB; Domenice S
Pediatr Nephrol; 2011 Aug; 26(8):1311-5. PubMed ID: 21559934
[TBL] [Abstract][Full Text] [Related]
55. Wilms tumor cells with WT1 mutations have characteristic features of mesenchymal stem cells and express molecular markers of paraxial mesoderm.
Royer-Pokora B; Busch M; Beier M; Duhme C; de Torres C; Mora J; Brandt A; Royer HD
Hum Mol Genet; 2010 May; 19(9):1651-68. PubMed ID: 20106868
[TBL] [Abstract][Full Text] [Related]
56. Identification of mutations in the WT1 gene in tumours from patients with the WAGR syndrome.
Baird PN; Groves N; Haber DA; Housman DE; Cowell JK
Oncogene; 1992 Nov; 7(11):2141-9. PubMed ID: 1331933
[TBL] [Abstract][Full Text] [Related]
57. Single-nucleotide polymorphism in WT1 gene in a hyperplastic intralobar nephrogenic rest with botryoid protrusion.
Mizuno K; Hayashi Y; Tozawa K; Iwatsuki S; Kojima Y; Kohri K
Urology; 2010 Jul; 76(1):149-52. PubMed ID: 19914700
[TBL] [Abstract][Full Text] [Related]
58. A novel WT1 mutation in a 46,XY boy with congenital bilateral cryptorchidism, nystagmus and Wilms tumor.
Terenziani M; Sardella M; Gamba B; Testi MA; Spreafico F; Ardissino G; Fedeli F; Fossati-Bellani F; Radice P; Perotti D
Pediatr Nephrol; 2009 Jul; 24(7):1413-7. PubMed ID: 19048299
[TBL] [Abstract][Full Text] [Related]
59. Prophylactic bilateral nephrectomies in two paediatric patients with missense mutations in the WT1 gene.
Hu M; Zhang GY; Arbuckle S; Graf N; Shun A; Silink M; Lewis D; Alexander SI
Nephrol Dial Transplant; 2004 Jan; 19(1):223-6. PubMed ID: 14671061
[TBL] [Abstract][Full Text] [Related]
60. Vertical transmission of a mutation in exon 1 of the WT1 gene: lessons for genetic counseling.
Regev M; Kirk R; Mashevich M; Bistritzer Z; Reish O
Am J Med Genet A; 2008 Sep; 146A(18):2332-6. PubMed ID: 18688870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
